Political Divide Shapes How Americans Judge Vaccine Safety and Effectiveness, National Survey Finds

A sweeping national survey of American adults has revealed how deeply political affiliation and underlying attitudes toward science shape the way people judge the safety and effectiveness of three of the most widely administered vaccines in the United States. The study, led by Dr. Dror Walter of the Department of Communication at Georgia State University in Atlanta and published online in the American Journal of Public Health on September 10, 2026, draws on a national probability sample of 1,763 US adults surveyed in November 2024. Its central finding is striking in its clarity: Republicans consistently reported less favorable perceptions of vaccine safety and effectiveness than Democrats, with the divide most pronounced for the COVID-19 vaccine, while the measles, mumps, and rubella vaccine enjoyed the most positive evaluations of the three vaccines examined.

The research team set out to move beyond a long-standing limitation in the vaccine hesitancy literature. Previous studies attempting to explain why some people resist vaccination have overwhelmingly measured attitudes toward science and scientists through a single lens: trust. Yet contemporary debates about vaccines, playing out across news media, social platforms, and everyday conversation, suggest that hesitancy is rarely reducible to simple mistrust or doubts about the competence of researchers. People may accept that scientists are skilled while questioning whether science is beneficial, whether scientific institutions are unbiased, whether scientific claims are credible, and whether scientific interventions are prudent. The new study therefore disaggregated perceptions of science and scientists into these distinct dimensions and tested how each related to vaccine evaluations across the political spectrum.

The technical architecture of the analysis rested on the national probability sample, a methodological gold standard that allows findings from roughly 1,763 respondents to be generalized to the adult population of the United States with quantifiable confidence. Fielded in November 2024, the survey captured perceptions of three vaccines that occupy very different positions in American public health history and political discourse: the measles, mumps, and rubella vaccine, a decades-old mainstay of childhood immunization schedules; the seasonal influenza vaccine, renewed annually and broadly familiar to the public; and the COVID-19 vaccine, developed at unprecedented speed during a global emergency and subsequently swept into partisan controversy.

The results painted a consistent hierarchy of public confidence. Respondents rated the MMR vaccine as the safest and most effective of the three, a verdict that aligns with its long track record and its relative insulation from recent partisan battles. The COVID-19 vaccine received the lowest ratings on both dimensions, perceived as neither as safe nor as effective as its older counterparts. The influenza vaccine fell between these poles. This ordering matters because perceived safety and perceived effectiveness are the twin psychological pillars on which vaccine acceptance rests; when either erodes, uptake tends to follow, and the consequences ripple outward through community immunity and disease transmission.

Political affiliation emerged as a powerful organizing variable. Republicans generally reported less favorable perceptions of vaccine safety and effectiveness than Democrats, and the gap widened dramatically for the COVID-19 vaccine, confirming that the politicization of that vaccine during and after the pandemic left a durable imprint on public judgment. The MMR and influenza vaccines, by contrast, showed smaller partisan differences, suggesting that the polarization surrounding COVID-19 immunization is not simply a generalized Republican skepticism of all vaccines but a vaccine-specific phenomenon rooted in the particular political history of the pandemic response.

Perhaps the most illuminating findings concerned the specific dimensions of perceptions of science and scientists. Across all three vaccines, one factor stood out for its consistency: perceiving science as beneficial was the strongest and most reliable correlate of positive vaccine evaluations. Americans who saw science as delivering tangible advantages to society were markedly more likely to rate each vaccine as safe and effective, regardless of party. This pattern held for the MMR vaccine, the flu vaccine, and the COVID-19 vaccine alike, making the perceived benefit of science the single most robust psychological predictor in the entire analysis.

Other dimensions of scientific perception showed more nuanced, politically contingent effects. Perceiving scientists as unbiased mattered more in Republicans’ assessments of the COVID-19 vaccine’s effectiveness, but played a comparatively smaller role among Democrats in evaluations of the MMR vaccine’s effectiveness. Dr. Walter offered a pointed interpretation of this asymmetry, noting that the difference is likely the result of attacks on the integrity of scientists during the COVID-19 pandemic from the right, as opposed to prepandemic concerns about the MMR vaccine from the left. In other words, when a community has been told repeatedly that scientists cannot be trusted to be impartial, the perceived impartiality of scientists becomes the decisive question for that group, whereas older vaccine controversies rooted in different political traditions activate different concerns.

The study’s framework implies that vaccine communication strategies built solely on appeals to trust may be leaving important levers unused. If resistance extends beyond mistrust or doubts about scientists’ competence, then interventions that address whether science is viewed as beneficial, credible, unbiased, and prudent may reach audiences that trust-based messaging misses. The finding that perceived benefit is the most consistently associated factor suggests that communication emphasizing the concrete, tangible benefits of science and vaccines, from prevented illnesses to protected communities, may be particularly effective, especially when tailored to the specific concerns and political context of the audience being addressed.

Such tailoring is not a matter of partisan pandering but of diagnostic precision. The data indicate that a communication strategy optimized for a Democratic audience evaluating the MMR vaccine may be poorly suited to a Republican audience evaluating the COVID-19 vaccine, because the psychological pathways underlying those judgments differ. For the latter group, evidence and messaging that directly address the integrity and impartiality of the scientific enterprise may carry disproportionate weight. For audiences weighing older vaccines, reinforcing the everyday benefits that science delivers may be the more productive route. The authors conclude that understanding vaccine perceptions benefits from examining both political affiliation and the multidimensional perceptions of science and scientists, an approach that offers practical insights for guiding tailored communication strategies rather than one-size-fits-all campaigns.

The implications extend well beyond the three vaccines studied. As public health authorities confront resurgent measles outbreaks, seasonal influenza burdens, and the ongoing task of maintaining COVID-19 immunization coverage, the study provides an evidence-based map of where public confidence stands and why it varies. It demonstrates that the American public does not hold a single undifferentiated attitude toward science but a bundle of distinct perceptions, each with its own political geography and its own relationship to vaccine judgment. For researchers, the work models a more granular approach to measuring science attitudes. For practitioners, it delivers a clear message: the path to higher vaccine confidence runs through demonstrating the benefits of science, defending the integrity of scientists where it has been called into question, and meeting audiences where their political experiences have shaped what they doubt and what they believe.

Subject of Research: Political affiliation and perceptions of science and scientists in relation to perceived vaccine safety and effectiveness in the United States

Article Title: American Journal of Public Health study examines political differences in perceptions of vaccine safety and effectiveness

Article References: American Journal of Public Health study examines political differences in perceptions of vaccine safety and effectiveness. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: vaccine hesitancy, vaccine safety, vaccine effectiveness, political affiliation, perceptions of science, MMR vaccine, COVID-19 vaccine, influenza vaccine, public health, health communication, survey research, American Journal of Public Health